vs
ICHOR HOLDINGS, LTD.（ICHR）与LifeStance Health Group, Inc.（LFST）财务数据对比。点击上方公司名可切换其他公司
LifeStance Health Group, Inc.的季度营收约是ICHOR HOLDINGS, LTD.的1.7倍（$382.2M vs $223.6M），LifeStance Health Group, Inc.净利率更高（3.1% vs -7.1%，领先10.2%），LifeStance Health Group, Inc.同比增速更快（17.4% vs -4.2%），LifeStance Health Group, Inc.自由现金流更多（$46.6M vs $5.9M），过去两年LifeStance Health Group, Inc.的营收复合增速更高（12.8% vs 5.4%）
Ichor Holdings Ltd.是面向全球半导体制造领域的关键流体输送系统、子系统及相关组件的设计、制造供应商，产品集成于晶圆前端加工设备，为北美、东亚、欧洲的领先半导体设备与芯片厂商提供先进逻辑、存储芯片生产配套支持。
LifeStance Health Group是美国的门诊行为健康服务提供商，支持线下面诊与远程诊疗两种服务模式，业务涵盖心理咨询、精神科诊疗、经颅磁刺激（TMS）以及氯胺酮治疗等。该公司曾多次因劳动违规、客户信息泄露及误导投资者相关问题遭遇诉讼。
ICHR vs LFST — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $223.6M | $382.2M |
| 净利润 | $-16.0M | $11.7M |
| 毛利率 | 9.4% | — |
| 营业利润率 | -6.2% | 4.7% |
| 净利率 | -7.1% | 3.1% |
| 营收同比 | -4.2% | 17.4% |
| 净利润同比 | -304.8% | 264.1% |
| 每股收益（稀释后） | $-0.46 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $223.6M | $382.2M | ||
| Q3 25 | $239.3M | $363.8M | ||
| Q2 25 | $240.3M | $345.3M | ||
| Q1 25 | $244.5M | $333.0M | ||
| Q4 24 | $233.3M | $325.5M | ||
| Q3 24 | $211.1M | $312.7M | ||
| Q2 24 | $203.2M | $312.3M | ||
| Q1 24 | $201.4M | $300.4M |
| Q4 25 | $-16.0M | $11.7M | ||
| Q3 25 | $-22.9M | $1.1M | ||
| Q2 25 | $-9.4M | $-3.8M | ||
| Q1 25 | $-4.6M | $709.0K | ||
| Q4 24 | $-3.9M | $-7.1M | ||
| Q3 24 | $-2.8M | $-6.0M | ||
| Q2 24 | $-5.1M | $-23.3M | ||
| Q1 24 | $-9.0M | $-21.1M |
| Q4 25 | 9.4% | — | ||
| Q3 25 | 4.6% | — | ||
| Q2 25 | 11.3% | — | ||
| Q1 25 | 11.7% | — | ||
| Q4 24 | 11.6% | — | ||
| Q3 24 | 13.2% | — | ||
| Q2 24 | 12.6% | — | ||
| Q1 24 | 11.4% | — |
| Q4 25 | -6.2% | 4.7% | ||
| Q3 25 | -8.1% | 2.0% | ||
| Q2 25 | -2.0% | -0.9% | ||
| Q1 25 | -0.5% | 0.5% | ||
| Q4 24 | -0.5% | 0.3% | ||
| Q3 24 | -0.2% | 0.0% | ||
| Q2 24 | -1.1% | -5.1% | ||
| Q1 24 | -1.9% | -5.6% |
| Q4 25 | -7.1% | 3.1% | ||
| Q3 25 | -9.6% | 0.3% | ||
| Q2 25 | -3.9% | -1.1% | ||
| Q1 25 | -1.9% | 0.2% | ||
| Q4 24 | -1.7% | -2.2% | ||
| Q3 24 | -1.3% | -1.9% | ||
| Q2 24 | -2.5% | -7.5% | ||
| Q1 24 | -4.5% | -7.0% |
| Q4 25 | $-0.46 | — | ||
| Q3 25 | $-0.67 | — | ||
| Q2 25 | $-0.28 | — | ||
| Q1 25 | $-0.13 | — | ||
| Q4 24 | $-0.11 | — | ||
| Q3 24 | $-0.08 | — | ||
| Q2 24 | $-0.15 | — | ||
| Q1 24 | $-0.30 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $98.3M | $248.6M |
| 总债务越低越好 | $123.5M | $282.8M |
| 股东权益账面价值 | $663.9M | $1.5B |
| 总资产 | $942.9M | $2.2B |
| 负债/权益比越低杠杆越低 | 0.19× | 0.19× |
8季度趋势，按日历期对齐
| Q4 25 | $98.3M | $248.6M | ||
| Q3 25 | $92.5M | $203.9M | ||
| Q2 25 | $92.2M | $188.9M | ||
| Q1 25 | $109.3M | $134.3M | ||
| Q4 24 | $108.7M | $154.6M | ||
| Q3 24 | $116.4M | $102.6M | ||
| Q2 24 | $114.3M | $87.0M | ||
| Q1 24 | $102.1M | $49.5M |
| Q4 25 | $123.5M | $282.8M | ||
| Q3 25 | $123.5M | $284.6M | ||
| Q2 25 | $125.0M | $286.4M | ||
| Q1 25 | $126.8M | $288.2M | ||
| Q4 24 | $128.5M | $290.0M | ||
| Q3 24 | $130.3M | $287.3M | ||
| Q2 24 | $130.2M | $288.0M | ||
| Q1 24 | $131.9M | $288.8M |
| Q4 25 | $663.9M | $1.5B | ||
| Q3 25 | $676.2M | $1.5B | ||
| Q2 25 | $694.1M | $1.5B | ||
| Q1 25 | $700.4M | $1.5B | ||
| Q4 24 | $698.3M | $1.4B | ||
| Q3 24 | $697.3M | $1.4B | ||
| Q2 24 | $694.9M | $1.4B | ||
| Q1 24 | $697.2M | $1.4B |
| Q4 25 | $942.9M | $2.2B | ||
| Q3 25 | $966.6M | $2.1B | ||
| Q2 25 | $985.1M | $2.1B | ||
| Q1 25 | $1.0B | $2.1B | ||
| Q4 24 | $995.6M | $2.1B | ||
| Q3 24 | $975.9M | $2.1B | ||
| Q2 24 | $947.7M | $2.1B | ||
| Q1 24 | $957.4M | $2.1B |
| Q4 25 | 0.19× | 0.19× | ||
| Q3 25 | 0.18× | 0.19× | ||
| Q2 25 | 0.18× | 0.19× | ||
| Q1 25 | 0.18× | 0.20× | ||
| Q4 24 | 0.18× | 0.20× | ||
| Q3 24 | 0.19× | 0.20× | ||
| Q2 24 | 0.19× | 0.20× | ||
| Q1 24 | 0.19× | 0.20× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $9.2M | $57.6M |
| 自由现金流经营现金流 - 资本支出 | $5.9M | $46.6M |
| 自由现金流率自由现金流/营收 | 2.6% | 12.2% |
| 资本支出强度资本支出/营收 | 1.5% | 2.9% |
| 现金转化率经营现金流/净利润 | — | 4.93× |
| 过去12个月自由现金流最近4个季度 | $-6.3M | $110.0M |
8季度趋势，按日历期对齐
| Q4 25 | $9.2M | $57.6M | ||
| Q3 25 | $9.2M | $27.3M | ||
| Q2 25 | $-7.5M | $64.4M | ||
| Q1 25 | $19.0M | $-3.1M | ||
| Q4 24 | $-2.5M | $62.3M | ||
| Q3 24 | $8.1M | $22.7M | ||
| Q2 24 | $17.5M | $44.1M | ||
| Q1 24 | $4.8M | $-21.8M |
| Q4 25 | $5.9M | $46.6M | ||
| Q3 25 | $2.1M | $17.0M | ||
| Q2 25 | $-14.8M | $56.6M | ||
| Q1 25 | $496.0K | $-10.3M | ||
| Q4 24 | $-6.9M | $56.0M | ||
| Q3 24 | $2.2M | $17.7M | ||
| Q2 24 | $14.6M | $39.0M | ||
| Q1 24 | $314.0K | $-26.9M |
| Q4 25 | 2.6% | 12.2% | ||
| Q3 25 | 0.9% | 4.7% | ||
| Q2 25 | -6.2% | 16.4% | ||
| Q1 25 | 0.2% | -3.1% | ||
| Q4 24 | -3.0% | 17.2% | ||
| Q3 24 | 1.0% | 5.7% | ||
| Q2 24 | 7.2% | 12.5% | ||
| Q1 24 | 0.2% | -9.0% |
| Q4 25 | 1.5% | 2.9% | ||
| Q3 25 | 3.0% | 2.8% | ||
| Q2 25 | 3.0% | 2.2% | ||
| Q1 25 | 7.6% | 2.2% | ||
| Q4 24 | 1.9% | 1.9% | ||
| Q3 24 | 2.8% | 1.6% | ||
| Q2 24 | 1.4% | 1.6% | ||
| Q1 24 | 2.2% | 1.7% |
| Q4 25 | — | 4.93× | ||
| Q3 25 | — | 25.34× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -4.36× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ICHR
| Other | $101.6M | 45% |
| US | $67.4M | 30% |
| Other Countries | $29.7M | 13% |
| Europe | $24.9M | 11% |
LFST
暂无分部数据
